Sentinel lymph node biopsy after neoadjuvant chemotherapy in inflammatory breast cancer.

@article{Hidar2009SentinelLN,
  title={Sentinel lymph node biopsy after neoadjuvant chemotherapy in inflammatory breast cancer.},
  author={Samir Hidar and Mohamed Bibi and Olfa Gharbi and Sameh Tebra and Amel Trabelsi and Sadok Korbi and Noureddine Bouaouina and Slim Ben Ahmed and H{\'e}di Kha{\"i}ri},
  journal={International journal of surgery},
  year={2009},
  volume={7 3},
  pages={
          272-5
        }
}
BACKGROUND Sentinel lymph node biopsy (SLNB) demonstrates promising results as an accurate alternative to axillary lymph node dissection in patients with locally advanced breast cancer after neoadjuvant chemotherapy (NAC). However and in the view of the insufficient data on women with inflammatory breast cancer (IBC), SLNB is not recommended in this situation. The current study assessed identification and false-negative rates of SLNB after NAC for patients with IBC. METHODS Between 2006 and… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 15 CITATIONS

Improved Locoregional Control in a Contemporary Cohort of Nonmetastatic Inflammatory Breast Cancer Patients Undergoing Surgery

Kelly J. Rosso, Audree B. Tadros, +7 authors Anthony Lucci
  • Annals of Surgical Oncology
  • 2017

Response Letter

  • Breast Cancer Research and Treatment
  • 2017
VIEW 2 EXCERPTS
CITES RESULTS

Timing of the sentinel lymph node biopsy in breast cancer patients receiving neoadjuvant therapy - recommendations for clinical guidance.

  • European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
  • 2013
VIEW 1 EXCERPT
CITES BACKGROUND